Koers MEDADVISO Australian S.E.
Aandelen
Geavanceerde medische apparatuur & technologie
Omzet 2024 * | 121 mln. 80,8 mln. 74,48 mln. | Omzet 2025 * | 140 mln. 92,97 mln. 85,7 mln. | Marktkapitalisatie | 242 mln. 161 mln. 148 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | - 0 0 | Nettowinst (verlies) 2025 * | 2 mln. 1,33 mln. 1,23 mln. | EV/omzet 2024 * | 1,92 x |
Nettoliquiditeiten 2024 * | 8,35 mln. 5,55 mln. 5,12 mln. | Nettoliquiditeiten 2025 * | 14,5 mln. 9,65 mln. 8,89 mln. | EV/omzet 2025 * | 1,63 x |
K/w-verhouding 2024 * |
-132
x | K/w-verhouding 2025 * |
-440
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 60,73% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Richard Ratliff
CEO | Chief Executive Officer | - | 15-07-22 |
Ancila Desai
DFI | Director of Finance/CFO | - | 17-10-22 |
Craig Schnuriger
CTO | Chief Tech/Sci/R&D Officer | - | 30-06-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Linda Jenkinson
CHM | Chairman | - | 28-02-22 |
Kevin Hutchinson
BRD | Director/Board Member | - | 23-11-22 |
Richard Ratliff
CEO | Chief Executive Officer | - | 15-07-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-9,49% | 28,16 mld. | |
+25,35% | 8,33 mld. | |
+33,25% | 4,39 mld. | |
-35,85% | 2,43 mld. | |
-9,44% | 1,6 mld. | |
-13,39% | 1,5 mld. | |
-32,84% | 1,15 mld. | |
+7,80% | 964 mln. | |
-37,56% | 872 mln. |